Skip to content

Evaluation of Standard of Care Practices, Procedural Outcomes and In-hospital Complications of Peripheral Endovascular Procedures

A Prospective, Multicenter, Observational Study Evaluating Standard of Care Practices, Procedural Outcomes, and In-hospital Complications of Endovascular Procedures for Treatment of Atherosclerotic Lesions in the Infrainguinal Arteries

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05831319
Acronym
BIO-OSCAR SOC
Enrollment
380
Registered
2023-04-26
Start date
2023-05-29
Completion date
2024-10-30
Last updated
2024-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease

Brief summary

Significant advances in dedicated materials and techniques along with increased operator experience led to a significant increment in procedural success rate of peripheral endovascular interventions, exceeding 90% in expert hands with reported low procedural complication rates. However, there are still lack of data on procedural outcomes, in-hospital complications, and resource utilization on treatment of (complex) lesions in the femoral, popliteal and infrapopliteal artery in the real-world condition in Europe.

Detailed description

The study will enroll consecutive eligible subjects who have peripheral artery disease (PAD) requiring endovascular treatment of de-novo and restenotic atherosclerotic lesions in femoral, popliteal and infrapopliteal arteries. The purpose of this prospective, multicenter, observational European Study is to evaluate the standard of care practices, procedural outcomes, and in-hospital complications of endovascular peripheral interventions for treatment of lesions in the femoral, popliteal and infrapopliteal arteries.

Interventions

None listed

Sponsors

Biotronik AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Subject ≥18 years old 2. Subject has provided written informed consent 3. Subject has Rutherford classification 2 to 6 4. Reference vessel diameter ≥2 and ≤7 mm 5. Target lesion(s) has stenosis \>70% by visual assessment 6. Multiple consecutive single lesions with a healthy segment(s) of ≤ 3cm in-between the lesions will be considered one lesion. For Above the knee (ATK) group 7. Target lesions located in the superficial femoral artery or popliteal arteries (above the tibial plateau) 8. At least 1 below-knee artery patent to the ankle 9. Successful treatment of inflow iliac stenosis to the target lesion. Inflow lesion stenosis can be treated during the same procedure as per local standard of care. For Below the knee (BTK) group: 10. Target lesions involve arteries below the tibial plateau 11. Successful treatment of inflow vessel (from ipsilateral iliac to the target lesion) resulting in ≤30% residual stenosis with no evidence of embolization or significant complications.

Exclusion criteria

1. Subject has a single target lesion that involves both ATK and BTK segment. 2. Subject not suitable for receiving endovascular procedures of lower limb arteries 3. Prior planned major amputation in the target limb (above the ankle) 4. Subject with previous bypass surgery of target vessel. 5. History of any open surgical procedure within the past 30 days. 6. Planned vascular surgery procedure within the next 30 days after the ATK and/or BTK procedure on the target limb. Note: The inflow vessels can be treated on the day of the procedure 7. Subject under dialysis 8. Subject currently enrolled in another investigational device, biologic, or drug trial in which the primary endpoint has not yet been reached 9. Subject lacking capacity to provide informed consent 10. Subject under judicial protection, tutorship, or curatorship (for France only)

Design outcomes

Primary

MeasureTime frameDescription
Procedural success rateIndex ProcedureCombination of technical success and absence of procedural complications

Secondary

MeasureTime frameDescription
Procedure technical success rateIndex Proceduresuccessful crossing and achievement of a final residual diameter stenosis of ≤30% of the treated target lesion on the procedural completion angiography
Rate of target lesion bailout stentingIndex ProcedureStented target lesion
Stented lengthIndex ProcedureStented length
Rate of PTA balloon related flow-limiting dissectionsIndex ProcedurePTA balloon related flow-limiting dissections
Rate of distal embolizationIndex ProcedureDistal embolization
Rate of target vessel ruptureIndex ProcedureTarget vessel rupture
Rate of acute occlusionIndex ProcedureAcute occlusion
Primary crossing success rateIndex ProcedureSuccessfully placement of a guidewire into the distal true lumen with the primary crossing strategy
Rate of Serious Adverse Device EffectsIndex ProcedureSerious Adverse Device Effects
Non-labor resource useIndex procedure until dischargeDevices use
Rate of target vessel perforationIndex ProcedureTarget vessel perforation

Countries

Austria, Belgium, France, Germany, Hungary, Italy, Spain, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026